These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24788349)
21. Down-regulation of PTEN by HCV core protein through activating nuclear factor-κB. Zhang Y; Li RQ; Feng XD; Zhang YH; Wang L Int J Clin Exp Pathol; 2014; 7(11):7351-9. PubMed ID: 25550771 [TBL] [Abstract][Full Text] [Related]
22. HBx-induced reactive oxygen species activates hepatocellular carcinogenesis via dysregulation of PTEN/Akt pathway. Ha HL; Yu DY World J Gastroenterol; 2010 Oct; 16(39):4932-7. PubMed ID: 20954279 [TBL] [Abstract][Full Text] [Related]
23. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP. Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208 [TBL] [Abstract][Full Text] [Related]
24. Oncogenic potential of CK2α and its regulatory role in EGF-induced HDAC2 expression in human liver cancer. Kim HS; Chang YG; Bae HJ; Eun JW; Shen Q; Park SJ; Shin WC; Lee EK; Park S; Ahn YM; Park WS; Lee JY; Nam SW FEBS J; 2014 Feb; 281(3):851-61. PubMed ID: 24616922 [TBL] [Abstract][Full Text] [Related]
25. HDAC2 provides a critical support to malignant progression of hepatocellular carcinoma through feedback control of mTORC1 and AKT. Noh JH; Bae HJ; Eun JW; Shen Q; Park SJ; Kim HS; Nam B; Shin WC; Lee EK; Lee K; Jang JJ; Park WS; Lee JY; Nam SW Cancer Res; 2014 Mar; 74(6):1728-38. PubMed ID: 24448241 [TBL] [Abstract][Full Text] [Related]
26. Targeted inhibition of ACK1 can inhibit the proliferation of hepatocellular carcinoma cells through the PTEN/AKT/mTOR pathway. Wang B; Song K; Chen L; Su H; Gao L; Liu J; Huang A Cell Biochem Funct; 2020 Jul; 38(5):642-650. PubMed ID: 32162707 [TBL] [Abstract][Full Text] [Related]
27. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway. Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896 [TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide induces G2/M arrest in hepatocellular carcinoma cells by increasing the tumor suppressor PTEN expression. Zhang X; Jia S; Yang S; Yang Y; Yang T; Yang Y J Cell Biochem; 2012 Nov; 113(11):3528-35. PubMed ID: 22730174 [TBL] [Abstract][Full Text] [Related]
29. Long Non-Coding RNA Linc-USP16 Functions As a Tumour Suppressor in Hepatocellular Carcinoma by Regulating PTEN Expression. Sui J; Yang X; Qi W; Guo K; Gao Z; Wang L; Sun D Cell Physiol Biochem; 2017; 44(3):1188-1198. PubMed ID: 29179215 [TBL] [Abstract][Full Text] [Related]
30. Involvement of PI3K/Akt pathway in the inhibition of hepatocarcinoma cell invasion and metastasis induced by SASH1 through downregulating Shh-Gli1 signaling. Sun C; Zhang Z; He P; Zhou Y; Xie X Int J Biochem Cell Biol; 2017 Aug; 89():95-100. PubMed ID: 28600143 [TBL] [Abstract][Full Text] [Related]
32. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway. Li Y; Ye Y; Feng B; Qi Y J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth. Kong D; Zhao L; Du Y; He P; Zou Y; Yang L; Sun L; Wang H; Xu D; Meng X; Sun X Int J Clin Exp Pathol; 2014; 7(11):7497-507. PubMed ID: 25550785 [TBL] [Abstract][Full Text] [Related]
34. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Jeong YJ; Choi Y; Shin JM; Cho HJ; Kang JH; Park KK; Choe JY; Bae YS; Han SM; Kim CH; Chang HW; Chang YC Food Chem Toxicol; 2014 Jun; 68():218-25. PubMed ID: 24675423 [TBL] [Abstract][Full Text] [Related]
35. Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway. Lu M; Fei Z; Zhang G Biomed Pharmacother; 2018 Jan; 97():1282-1288. PubMed ID: 29156516 [TBL] [Abstract][Full Text] [Related]
36. Aberrant regulation of HDAC2 mediates proliferation of hepatocellular carcinoma cells by deregulating expression of G1/S cell cycle proteins. Noh JH; Jung KH; Kim JK; Eun JW; Bae HJ; Xie HJ; Chang YG; Kim MG; Park WS; Lee JY; Nam SW PLoS One; 2011; 6(11):e28103. PubMed ID: 22132221 [TBL] [Abstract][Full Text] [Related]
37. MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression. Ma Q; Zhang Y; Meng R; Xie KM; Xiong Y; Lin S; He ZL; Tao T; Yang Y; Zhao JZ; He JQ Biomed Environ Sci; 2015 Jul; 28(7):502-9. PubMed ID: 26248734 [TBL] [Abstract][Full Text] [Related]
38. [Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis]. Guo SP; Wang L; Wang WL; Li QL; Wang WY; Zhang J Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):467-72. PubMed ID: 17069699 [TBL] [Abstract][Full Text] [Related]
39. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism]. Lin F; Yan W; Wen T; Wu GY Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094 [TBL] [Abstract][Full Text] [Related]
40. DJ-1 knockdown inhibits growth and xenograft‑induced tumor generation of human hepatocellular carcinoma cells. Liu S; Long G; Wei H; Shi L; Yang Z; Liu D; Hu G; Qiu H Oncol Rep; 2015 Jan; 33(1):201-6. PubMed ID: 25384406 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]